Brazilian researchers are getting closer to finding ways of treating Alzheimer’s disease, which affects 1 million people in the country and 50 million people worldwide, according to the 2018 World Alzheimer Report. By 2050, that number is expected to triple. The neurodegenerative illness causes dementia, loss of memory and cognitive ability, delusions and mood swings.
Alzheimer’s disease is caused by the accumulation of plaques that cause the death of neurons and the subsequent loss of brain function. Currently, available medication can only ease the symptoms but do not have an effect on the development of the disease itself. That could be about to change with the research conducted by the Federal University of Rio de Janeiro (UFRJ).